<DOC>
	<DOCNO>NCT00825045</DOCNO>
	<brief_summary>This study provide information regard dopamine D2/D3 occupancy relate clinical/adverse effect older people schizophrenia schizoaffective disorder . The result study also show appropriate dose range order evade undesirable adverse effect derive therapeutic effect , directly serve guide physician clinical practice . Furthermore , finding study elucidate mechanism underlie old people 's increase sensitivity antipsychotic drug . In addition , contribution D2 D3 mediate antipsychotic response contrast , use 2 radiotracers , never test old population . The hypothesis follow : First , clinical response ( i.e. , â‰¥ 20 % decrease Brief Psychiatric Rating Scale total score ) achieve old patient occupancy low threshold 60 % historical young control . Second , prolactin elevation EPS detect old patient occupancy low threshold 72 78 % report historical young control . Third , dopamine D2 receptor occupancy inversely correlate subjective well-being . Fourth , bind potential receptor occupancy least 20 % low [ 11C ] - ( + ) -PHNO [ 11C ] -raclopride caudate/putamen . Fifth , bind [ 11C ] - ( + ) -PHNO globus pallidus high [ 11C ] -raclopride .</brief_summary>
	<brief_title>Dopamine D2 D3 Receptor Occupancy Clinical Response Older Patients With Schizophrenia</brief_title>
	<detailed_description>Positron Emission Tomography ( PET ) study demonstrate therapeutic window dopamine D2/3 receptor occupancy ( 60-80 % ) associate clinical response young patient schizophrenia . This observation use predict therapeutic dose range contribute current recommend antipsychotic dos . To date , publish report examine D2/3 receptor occupancy associate clinical response old individual primary psychotic disorder . This impeded implementation treatment guideline . The investigator therefore propose prospective study assess dopamine D2 D3 receptor occupancy follow acute antipsychotic treatment patient age 50 old schizophrenia currently receive antipsychotic treatment , use [ 11C ] - ( + ) -PHNO [ 11C ] -raclopride PET scan . Dopamine D2/3 receptor occupancy risperidone associate clinical effect measure , use PET , old patient schizophrenia . The investigator also try contrast contribution D2 D3 mediate antipsychotic response , use 2 radiotracers . Our primary goal relate change clinical outcome , include subjective objective clinical rating , dopamine D2 D3 receptor occupancy old patient schizophrenia , compare result data young patient literature .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Age 50 old time scan Inpatients outpatient DSMIV/SCID diagnosis schizophrenia , schizoaffective disorder , schizophreniform disorder Having NOT treated oral antipsychotic treatment least 2 week longacting antipsychotic least 6 month ( Please note patient withdraw antipsychotic medication purpose meet inclusion criterion study ) . Known history intolerance inefficacy risperidone Participation study would result exceed annual radiation dose limit ( 20 mSv ) human subject participate research study . Substance abuse dependence ( within past six month ) Positive urine drug screen Positive serum pregnancy test screen positive urine pregnancy test PET scan Metal implant pacemaker would preclude MRI scan History head trauma result loss consciousness &gt; 30 minute require medical attention Unstable physical illness significant neurological disorder include seizure disorder Inappropriate size head , neck , body able fit PET MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>dopamine</keyword>
	<keyword>D2</keyword>
	<keyword>D3</keyword>
	<keyword>caudate</keyword>
	<keyword>putamen</keyword>
	<keyword>globus pallidus</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>risperidone</keyword>
	<keyword>geriatric</keyword>
	<keyword>Brief Psychiatric Rating Scale</keyword>
	<keyword>PET</keyword>
	<keyword>radiotracer</keyword>
	<keyword>[ 11C ] - ( + ) -PHNO</keyword>
	<keyword>[ 11C ] -raclopride</keyword>
</DOC>